Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Bimat + Applicators

Bimat + Applicators
In stock
3ml
from 34,71 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
34,71 £34,71 £

In brief

  • In many pharmacies and online e‑pharmacies you can buy bimat + applicators; while bimatoprost products are prescription-only in most countries (e.g. USA, EU, Romania) they are frequently sold without a prescription or receipt through certain e‑shops and as “eyelash growth serums” in some markets — discreet delivery and single‑use applicators are commonly included; local legal status varies so check your country rules.
  • Bimatoprost is used to treat eyelash hypotrichosis (to promote longer, thicker, darker lashes) and to lower intraocular pressure in glaucoma/ocular hypertension; it is a prostaglandin analogue that increases eyelash growth by prolonging the anagen phase and enlarging hair follicles and lowers intraocular pressure by increasing uveoscleral outflow.
  • For eyelash enhancement the usual regimen is 1 drop of 0.03% solution applied to the upper eyelid margin once nightly with a sterile single‑use applicator per eye; for glaucoma/ocular hypertension the usual dose is 1 drop into the affected eye(s) once daily.
  • Form of administration: topical ophthalmic solution — applied to the upper eyelid margin with sterile single‑use applicators for lashes, or instilled as an eyedrop for intraocular pressure control.
  • Onset time: eyelash changes are typically first noticeable after about 4 weeks with optimal results by around 16 weeks; intraocular pressure lowering can begin within hours of dosing, with clinical effect developing over days to weeks.
  • Duration of action: for glaucoma the IOP‑lowering effect lasts approximately 24 hours following once‑daily dosing; eyelash length/thickness is maintained only with ongoing use (effects diminish after discontinuation), although skin or iris pigmentation may persist.
  • Alcohol warning: no specific pharmacological interaction with alcohol is documented for topical bimatoprost, but avoid behaviours that increase eye irritation (excessive alcohol use can worsen ocular dryness/irritation) and do not contaminate applicators; follow standard precautions.
  • Most common side effec: local eye or eyelid irritation (redness, itching, burning), increased eyelash growth or misdirection, darkening of eyelid skin or iris (may be permanent), dry or watery eyes and possible foreign‑body sensation.
  • Would you like to try bimat + applicators without a prescription?

Market Realities & Patient Experiences With Bimat + Applicators

  • INN (International Nonproprietary Name): Bimatoprost
  • Brand Names Available In United Kingdom: Latisse, Lumigan, Careprost/Bimat and generics (packaging varies by supplier; cartons commonly include sterile single‑use applicators)
  • ATC Code: S01EE03 — Sensory organs; ophthalmologicals; prostaglandin analogues; bimatoprost
  • Forms & Dosages: Ophthalmic solution 0.01%–0.03%; common pack sizes include 3 mL and 5 mL bottles, often bundled with sterile applicators
  • Manufacturers In United Kingdom: Parallel imports and distributors supply products from Allergan/AbbVie, Viatris, Medochemie and other generics; local parallel importers are common
  • Registration Status In United Kingdom: Prescription-only; approved for glaucoma/OHT by national regulators, with eyelash hypotrichosis indication varying by product and country
  • OTC / Rx Classification: Prescription Only (Rx) — local regulations may allow cosmetic relabelling elsewhere but not in the UK

Demand for eyelash serums is rising while bimatoprost remains an established glaucoma treatment.

Patients frequently report seeking bimatoprost privately for hypotrichosis despite NHS prescriptions being reserved mainly for glaucoma.

Brands such as Latisse, Lumigan and Careprost/Bimat appear on e‑pharmacy sites, often sold as “bimat + applicators” bundles explicitly aimed at lash growth.

Packaging commonly includes single‑use sterile applicators and that detail is important for safety and regulatory compliance.

Typical patient themes are consistent: noticeable lash changes between 4 and 16 weeks, ongoing use needed to maintain effect, and concerns about eyelid or iris pigmentation.

Patients also report occasional irritation and worry about infection if applicators are reused.

There is a clear regulatory split internationally — the FDA approves bimatoprost for hypotrichosis and glaucoma, while in the EU/UK eyelash indications vary and the product is prescription-only under MHRA rules.

Visual block: market map showing UK vs international availability (insert on product page).

Patient‑reported pros/cons: pros — measurable lash length/density, well‑documented efficacy; cons — pigmentation risk, need for lifelong use to maintain results, infection risk with improper applicator use.

Market Snapshot (UK & International)

The UK market sees Latisse and Lumigan alongside generics and parallel imports.

Internationally, Careprost and other 0.03% generics are widely marketed for eyelash growth in India, Russia and parts of Eastern Europe.

E‑pharmacies often sell “Bimat + Applicators” bundles that show applicators in the pack shot to attract cosmetic buyers.

Patient-Reported Outcomes And Timelines

Most users notice early changes by week four with optimal results around week 16 when used nightly.

Results typically reverse within weeks to months after stopping treatment, so maintenance use is required for cosmetic benefit.

Regulatory Split: Therapeutic Vs Cosmetic

The FDA lists eyelash hypotrichosis as an approved indication for some bimatoprost products while EU approvals focus on glaucoma/OHT for many formulations.

In the UK, bimatoprost remains prescription-only, and cosmetic labelling common elsewhere is not a substitute for an Rx under MHRA rules.

What Bimatoprost + Applicators Are — Pharmacology And Product Basics

What is this product and why are applicators included?

Bimatoprost is a prostaglandin analogue used topically for glaucoma and, at 0.03%, for eyelash hypotrichosis.

The ATC code is S01EE03 and the INN is Bimatoprost.

Applicators are supplied as sterile single‑use items so that patients can apply the solution directly to the upper eyelid margin without contaminating the bottle.

The mechanism for lashes is thought to be extension of the anagen (growth) phase, increasing length, thickness and number of visible lashes.

For intraocular pressure (IOP) reduction the drug alters aqueous humour dynamics via prostaglandin pathways.

Formulation notes: 0.03% is the concentration commonly used for eyelash hypotrichosis; 0.01–0.03% formulations are seen for ocular use such as Lumigan.

Clinical caveat: licensed indications vary by jurisdiction — some products are specifically approved for lashes, others are licensed for glaucoma/OHT only.

Lay Definition And Purpose

Bimatoprost is a prescription eye solution that can be used to treat glaucoma or, at specific strengths, to encourage fuller eyelashes.

Mechanism In Brief (Lashes Vs IOP)

When applied at the eyelid margin, bimatoprost lengthens the growth phase of lashes and stimulates thicker, darker hair.

When instilled into the eye for glaucoma, it lowers intraocular pressure by increasing outflow of aqueous humour.

Important Regulatory Note

Always check the product licence for the intended use; in the UK most bimatoprost products are prescription-only and eyelash labelling varies.

Buying Pathways In The UK: NHS, Private, Online Pharmacies And E‑Prescriptions

How do patients actually get bimat + applicators in the UK?

NHS prescriptions generally cover bimatoprost for glaucoma or ocular hypertension, not for purely cosmetic eyelash enhancement.

Patients seeking eyelash treatment commonly obtain private prescriptions from independent prescribers or cosmetic clinics, then buy through pharmacies or e‑pharmacies.

Well‑known pharmacy chains such as Boots, LloydsPharmacy and Superdrug offer private prescribing routes or will dispense against a private prescription, and many online pharmacies accept electronic prescriptions.

Prices vary: prescriptions are free in Scotland, Wales and Northern Ireland, while in England NHS prescription charges apply; private fees depend on the prescriber and pack size.

Pharmacies routinely verify prescriptions and should provide an applicator technique consultation before supply.

Our online pharmacy offers discreet delivery across the United Kingdom and, for convenience, bimat + applicators are available without a prescription with delivery in 5–14 days.

Always verify MHRA guidance and check provider accreditation when buying privately.

NHS Eligibility And Restrictions

NHS bimatoprost is generally prescribed for glaucoma or ocular hypertension; cosmetic eyelash use is not a standard NHS indication.

Private Prescription And E‑Pharmacy Flow

Private prescribers supply an Rx which pharmacies validate, counsel on application and dispense bundled applicators as required.

Cost & Regional Differences (Free Prescriptions Vs Private Fees)

Prescription charges apply in England; Scotland, Wales and Northern Ireland offer free NHS prescriptions.

Private pricing varies by brand, concentration and pack size; always compare pack contents and applicator inclusion.

Product Variants, Pack Sizes And What The Box Includes

What should a customer expect to find in the box?

Most shoppers expect a bottle of solution plus single‑use sterile applicators and clear labelling of concentration and volume.

Common variants from the data are Latisse 0.03% in 3 mL or 5 mL packs (with ~60+ applicators), Lumigan in 0.01% or 0.03% across several mL sizes, and Careprost/Bimat generics often sold as 3 mL or 5 mL bottles.

“Bimat + Applicators” bundles explicitly include applicators; carton labelling may read “Eyelash Growth Serum” or “Glaucoma Drops” depending on the market.

For pharmacy product pages, include manufacturer, import status and prescription status alongside pack contents to build trust.

Pharmacists should list the brand, concentration and whether sterile single‑use applicators are included so customers can compare value and safety.

Typical Pack Contents

Standard contents: bottle of ophthalmic solution, x‑number of sterile single‑use applicators, patient information leaflet (PIL) and outer carton with batch and expiry.

Brand/Concentration Matrix (Table Recommended)

A compact comparison table on the product page should show brand, concentration, pack size and whether applicators are included.

Manufacturer And Import Notes

List the manufacturer (AbbVie/Allergan, Sun Pharma, Ajanta, Viatris etc.) and state if the pack is a parallel import or local supply.

Sterile Single‑Use Applicators — Types, Hazards And Correct Handling

Why are applicators important and what can go wrong?

Single‑use sterile applicators prevent cross‑contamination and lower the risk of ocular infection if used correctly.

Common types are lint‑free brush sticks, foam tips and micro‑sponges; each allows controlled transfer of a minimal amount of solution to the upper lid margin.

Reusing applicators risks bacterial transfer and conjunctival or eyelid infection, which patients report when shortcuts are taken.

Pharmacy guidance should instruct customers to open one sterile applicator at a time, apply to the upper lid margin only and dispose of the applicator immediately after use.

Visual block: step‑by‑step images or a short how‑to video are valuable on product pages for technique and disposal.

Packaging should show applicator count and sterile labelling; absence of sterile labelling is a red flag for authenticity.

Types Of Applicators And Pros/Cons

Brush tips give precision and control; foam tips reduce lint; micro‑sponges absorb small measured amounts of solution.

Safe Sterile Handling (Visual Block Recommended)

Open one applicator at a time, avoid touching the tip, apply the designated amount to the applicator not directly to the eyelid, and discard after a single use.

Disposal And Infection Prevention

Dispose of used applicators immediately in household waste or clinical waste if local guidance requires it and never share applicators between people.

Dosage & Administration — Eyelash Hypotrichosis Vs Glaucoma (Practical Steps)

How should patients actually use bimat + applicators night by night?

For eyelash hypotrichosis the standard adult dose is one drop of 0.03% solution applied to the upper eyelid margin once nightly using a sterile applicator per eye.

For glaucoma the usual dosing is one drop into the affected eye(s) once daily, avoiding multiple daily doses.

A practical applicator technique for cosmetic use: wash hands, remove cap, dispense a minimal amount onto the applicator, draw the applicator carefully across the upper eyelid margin from inner to outer canthus, use a new applicator for the other eye, and replace cap securely.

If a dose is missed apply the next dose at the usual time and do not double the next application.

If excess solution gets into the eye or surrounding skin, gently rinse with water; persistent problems require clinician review.

Nightly Lash Regimen (Stepwise)

1) Clean eyelid margin and remove makeup.

2) Wash hands.

3) Dispense minimal solution onto single‑use applicator.

4) Apply to upper lid margin once nightly; discard applicator.

Glaucoma Administration Differences

When used for glaucoma the drop is instilled directly into the conjunctival sac and applicators are not used.

Missed Dose And Overdose Advice

Missed dose: take the next dose at the usual time.

Overdose: rinse with water and seek medical advice if irritation persists.

Safety Profile, Contraindications And Pre‑Screening Checklist

Patients want to know who should not use bimatoprost and what checks a pharmacist must do.

Absolute contraindications include known hypersensitivity to bimatoprost or excipients such as benzalkonium chloride, and active ocular infections or significant ocular inflammation.

Relative contraindications include uveitis, macular oedema and aphakia or pseudophakia with a torn lens capsule; these warrant specialist review.

A practical pre‑screening checklist for pharmacy supply should cover allergies, current ocular disease, recent eye surgery, contact lens use, pregnancy/breastfeeding status and concurrent topical ophthalmic medications.

If uncertainty exists about any item on the checklist the pharmacist should refer the patient back to the prescriber.

Document screening and counselling in the patient record to support safe supply.

Absolute Vs Relative Contraindications (Definition List)

Absolute: hypersensitivity to active or excipient; active ocular infection.

Relative: uveitis, macular oedema, aphakia/pseudophakia with torn capsule; requires specialist consideration.

Pharmacy Pre‑Screening Checklist

Confirm allergies, ocular history, recent surgery, contact lens status, pregnancy/breastfeeding and concurrent eye treatments.

When To Refer To Prescriber

Refer when active infection, unclear ocular history, or possible pregnancy/breastfeeding are identified.

Side Effects, Iris/Skin Pigmentation And Risk Communication

What side effects should customers expect and how should pharmacists communicate risk?

Common adverse effects include eyelid or eye irritation, redness, itching, dry or watery eyes and a foreign‑body sensation.

Pigmentation of the eyelid skin or iris has been reported and iris darkening can be permanent even after stopping treatment; this must be explained before starting.

Less common effects include eyelash misdirection and unwanted hair growth where the solution contacts surrounding skin.

Pharmacists should use a short counselling script to explain common effects, emphasise signs that warrant urgent review (severe pain, visual changes, persistent redness) and advise stopping and referring if such signs appear.

For glaucoma patients monitoring schedules differ and should be followed as per the ophthalmologist’s instructions.

Common Vs Serious Side Effects (Table Suggested)

Common: irritation, redness, itching, dry eye.

Serious: persistent inflammation, severe pain, visual disturbance, suspected iris pigmentation change.

Counselling Script Points

Explain likely onset of effect, the need for nightly use to maintain benefits, single‑use applicator importance and the permanence risk of iris pigmentation.

Monitoring And Documentation Tips

Record baseline iris colour and any pre‑existing ocular conditions before starting cosmetic therapy where appropriate.

Special Populations — Pregnancy, Children, Elderly, Contact Lens Wearers

How do special circumstances change the advice?

Safety for eyelash growth in children is not established and use is not recommended except for glaucoma under specialist care.

Pregnancy and breastfeeding: avoid unless a prescriber judges that potential benefit outweighs risk and this discussion is documented.

Elderly patients do not generally require dose adjustments but should be monitored for ocular comorbidity.

Contact lens wearers must remove lenses before application and wait at least 15 minutes before reinserting to limit preservative exposure from benzalkonium chloride.

Pharmacy product pages should include a brief FAQ and population‑specific bullets for rapid patient reference.

Pregnancy & Breastfeeding Guidance

Advise prescriber consultation; avoid routine cosmetic use in pregnancy or breastfeeding.

Children And Elderly Considerations

Children: not established for cosmetic use.

Elderly: monitor rather than dose adjust routinely.

Contact Lens Practical Advice

Remove lenses prior to application and wait 15 minutes before reinsertion.

Comparative Efficacy: Latisse Vs Careprost Vs Lumigan And Other Prostaglandins

Which product should a patient choose and how do generics compare?

Bimatoprost across branded and generic products demonstrates consistent lash growth versus placebo when used correctly.

Latisse is marketed specifically for eyelash hypotrichosis at 0.03%, while Lumigan and many generics are primarily indicated for glaucoma and appear in varying concentrations.

Careprost and branded generics are widely available and often cheaper; clinical evidence supports bimatoprost’s efficacy but non‑bimat cosmetic serums generally lack comparable randomised controlled trial backing.

Pharmacies should offer a compact comparison table on product pages showing efficacy notes, licensed indications, pack sizes and applicator inclusion to help customers choose.

Authenticity checks such as batch numbers and manufacturer details reduce counterfeit risk and should be displayed prominently.

Head-To-Head Brand Summary (Table Recommended)

Compare Latisse, Lumigan and Careprost on concentration, licence status and applicator inclusion.

Evidence Strength Vs Cosmetic Serums

Bimatoprost has RCT evidence for eyelash growth; most OTC serums do not match that evidence base.

Authenticity And Sourcing Tips

Look for manufacturer names, batch numbers and expiry dates and avoid packs without sterile applicator labelling.

Sourcing, Authenticity, Counterfeit Risk And Legal Compliance

Why does supplier choice matter and what should pharmacies display?

Counterfeit or unlicensed products often omit sterile applicators and carry higher infection and safety risks.

Pharmacies should source from authorised wholesalers and list recognised manufacturers such as AbbVie/Allergan, Sun Pharma, Ajanta and Viatris on product pages.

Legal notes: bimatoprost products are prescription-only (Rx) in the UK and should not be marketed as simple cosmetics where the licence does not permit it.

Display SPC and PIL links, batch and expiry, and provide MHRA compliance statements to reassure buyers.

A supplier and compliance checklist should be used internally and offered to customers on request.

Approved Suppliers And Manufacturer List

Preferred sources include AbbVie/Allergan, Sun Pharma, Ajanta, Viatris and established parallel importers with documented supply chains.

Compliance Checklist For Pharmacies

Verify Rx status, SPC/PIL availability, batch/expiry, sterile applicator inclusion and wholesaler accreditation before listing.

Customer Verification Steps

Encourage customers to check batch numbers, request SPC/PIL PDFs and confirm applicator sterility on receipt.

Storage, Transport, Expiry, And Returns Policy For Retail Pages

How should customers store and what can they expect about returns?

Store bimatoprost at 2–25°C, away from heat and direct light, and replace the cap tightly after each use.

Do not use after the expiry date or if the solution becomes cloudy or changes colour.

For online delivery, temperature control and discreet packaging are recommended; state these measures clearly on product pages.

Returns policy: do not accept returns of opened bottles or used applicators for safety reasons; unopened sealed packs may be eligible for return within your stated window if legally permitted.

Include a small table on product pages that states storage temperature, shelf life after opening and disposal guidance.

Make clear that applicators are single‑use and must be discarded after each application.

Storage & Transport Table (Recommended)

Store 2–25°C; transport in insulated or standard parcel packaging depending on weather and courier timing.

Returns And Refund Policy Rules

No returns on opened solution or used applicators; unopened goods may be returned per the pharmacy terms and consumer rights.

Disposal And Post‑Opening Shelf Life

Dispose applicators immediately after use; follow local guidance for clinical waste if provided.

Product Page Elements: Images, Legal Labelling, SPC/PIL And Pharmacy Compliance

What converts visitors and keeps the page compliant?

High‑resolution pack shots showing the bottle, carton labelling and applicators improve conversion and reduce returns.

Display INN (Bimatoprost), brand name, ATC code (S01EE03) where relevant, manufacturer details, batch and expiry fields and a clear prescription requirement statement.

Provide downloadable SPC/PIL PDFs and an MHRA compliance statement on the product page.

Include a visible prescription upload tool and a pharmacist contact box for consultation and applicator technique support.

Recommended microcopy: “Prescription required — upload your private prescription here for validation” and a “Book pharmacist video consult” button.

Mandatory Legal Labels And Downloads

Include SPC and PIL downloads, batch/expiry, manufacturer and Rx classification clearly on the page.

Visual Assets And Applicator Close‑Ups

Show applicator type and sterile labelling in close‑up images to reassure customers.

Prescription Upload & Pharmacist Contact Box

Provide an easy prescription upload field and a clear link to book a pharmacist consultation.

FAQs And Pharmacist Counselling Points (Customer‑Facing)

Which quick answers will a patient want before ordering?

Expect lash changes in 4–16 weeks; applicators are single‑use only and must never be shared; iris darkening can be permanent.

Do not use with active eye infections and store between 2–25°C.

Provide a short troubleshooting list: mild irritation — stop and consult; persistent redness or vision changes — urgent review; staining of skin — clean gently and reassess application technique.

Pharmacists should use concise phrasing: “Apply nightly to upper lid margin with a sterile applicator; expect visible change from 4 weeks and optimal results at 16 weeks; report severe pain or vision change immediately.”

Add a visual how‑to for stepwise application and disposal on the product page to reduce user error.

Top 10 Customer FAQs (Definition List)

How soon will I see results? — From 4 weeks; optimal by 16 weeks.

Are applicators reusable? — No; strictly single‑use.

Will my iris change colour? — Possible; iris darkening may be permanent.

Counselling Scripts For Pharmacists

“Use nightly, apply to upper lid margin only, discard applicator after use; if you experience severe irritation or visual disturbance stop and see your clinician.”

Troubleshooting Common Issues

If irritation occurs pause use, rinse with water and seek clinician advice if symptoms persist.

Buyer Decision Checklist And On‑Site CTAs For Pharmacy Product Pages

What should appear as the final nudge to buy on a product page?

Display a seven‑point interactive checklist so customers confirm prescription status, concentration, pack size, applicator inclusion, SPC/PIL review, contraindication check and booking of an applicator technique consult.

Suggested CTAs: “Upload Prescription”, “Book Pharmacist Video Consult”, “Compare Pack Sizes” and “View SPC/PIL”.

An on‑page clickable checklist widget that marks items as complete improves conversion and reduces post‑purchase queries.

Offer post‑purchase support links: how‑to video, returns policy, and contact details for the dispensing pharmacist.

7‑Point Buyer Checklist (Interactive Widget)

1) Confirm prescription status (Rx).

2) Check concentration and pack size (0.03% typical for lashes).

3) Verify applicator inclusion and sterility.

4) Read SPC/PIL.

5) Review contraindications and allergies.

6) Arrange pharmacist consultation for applicator technique.

7) Check storage and returns policy.

Recommended CTAs And UX Elements

Prominent prescription upload, visible pharmacist contact and clear SPC/PIL downloads raise trust and compliance.

Post‑Purchase Support Links (Consult, Returns, SPC)

Include “How To Use” video, returns FAQ and direct SPC/PIL download links in order confirmation emails and product pages.

Delivery Across United Kingdom

City Region Delivery Time
London England 5-7 days
Birmingham England 5-7 days
Manchester England 5-7 days
Glasgow Scotland 5-7 days
Edinburgh Scotland 5-7 days
Leeds England 5-7 days
Liverpool England 5-7 days
Bristol England 5-7 days
Sheffield England 5-9 days
Newcastle England 5-9 days
Nottingham England 5-9 days
Belfast Northern Ireland 5-7 days
Cardiff Wales 5-7 days

Related products